Home
>
US Stocks
>
Design Therapeutics Inc
Design Therapeutics Inc
DSGN

Design Therapeutics Inc

$14.2111.46%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
14.65
Today Low/High
14 / 15.14
52 Week Low/High
$14.39 / $50.5
Market Cap
$882.09M

Company Details

Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.
Organisation
Design Therapeutics Inc
Employees
15

Discover more

Frequently Asked Questions

What is Design Therapeutics Inc share price today

Can Indians buy Design Therapeutics Inc shares?

How can I buy Design Therapeutics Inc shares from India?

Can Fractional shares of Design Therapeutics Inc be purchased?

What are the documents required to start investing in Design Therapeutics Inc stocks?

We are a SEBI registered investement advisor